中文名稱:4-oxo-27-TBDMS Withaferin A | 英文名稱:4-oxo-27-TBDMS Withaferin A |
CAS:1214886-31-3 | 品牌: 一研 |
保存條件: Store at -20°C | 產(chǎn)品類別: 抑制劑 |
Cas : 1214886-31-3 |
產(chǎn)品屬性:
產(chǎn)品名稱 | 規(guī)格 | CAS號 | 型號 |
4-oxo-27-TBDMS Withaferin A | 1mg 5mg 10mg | 1214886-31-3 | EY-Y0165071 |
Cas No.1214886-31-3
別名 N/A
化學(xué)名 N/A
分子式 C34H50O6Si
分子量 582.9
溶解度 DMF: 5mg/mL,DMSO: 5mg/mL,DMSO:PBS (pH 7.2) (1:1): 0.5mg/mL
儲存條件 Store at -20°C
General tips For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.
Shipping Condition Evaluation sample solution : ship with blue ice
All other available size: ship with RT , or blue ice upon request
產(chǎn)品描述:
4-oxo-27-TBDMS Withaferin A is a derivative of the steroidal lactone withaferin A that has anticancer activity.1 It is cytotoxic to A2780 ovarian cancer cells (IC50 = 17 μM) but not to carboplatin-resistant A2780 (A2780/CP70) cells (IC50 = >100 μM). It is selective for A2780 cells over non-cancerous ARPE19 cells (IC50 = 1,660 μM). 4-oxo-27-TBDMS Withaferin A induces DNA fragmentation in A2780 cells.
References
1. Perestelo, N.R., Llanos, G.G., Reyes, C.P., et al. Expanding the chemical space of withaferin A by incorporating silicon to improve its clinical potential on human ovarian carcinoma cells. J. Med. Chem. 62(9), 4571-4585 (2019).
成立日期 | 2014-06-05 (11年) | 注冊資本 | 100 |
員工人數(shù) | 50-100人 | 年營業(yè)額 | ¥ 100萬以內(nèi) |
主營行業(yè) | 生化試劑,抗體,細胞培養(yǎng),分子生物學(xué),免疫安全 | 經(jīng)營模式 | 工廠,試劑 |
產(chǎn)品名稱 | 價格 | 公司名稱 | 報價日期 | |
---|---|---|---|---|
詢價 |
合肥華納生物醫(yī)藥科技有限公司
|
2024-12-28 | ||
詢價 |
VIP2年
|
上海科澤永欣生物科技有限公司
|
2025-01-22 | |
詢價 |
VIP3年
|
陜西締都醫(yī)藥化工有限公司
|
2024-12-18 | |
¥6930 |
VIP1年
|
TargetMol中國(陶術(shù)生物)
|
2024-12-02 |